Trial Profile

a Phase 2 study of DISC-0974 in anemia of myelofibrosis (MF)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 07 Sep 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Selcodebart (Primary)
Indications Anaemia; Myelofibrosis
Focus Therapeutic Use
Acronyms RALLY-MF

Most Recent Events

31 Aug 2026 According to a Disc Medicine media release, company will present an abstract of initial efficacy data from RALLY-MF trial at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026.
30 Jul 2026 According to a Disc Medicine media release, additional data from this trial in anticipated Q4 2026.
30 Jul 2026 Results presented in the Disc Medicine media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com